Literature DB >> 19051331

Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats.

Su-zhen Jiang1, Ning-sheng Wang, Sui-qing Mi.   

Abstract

[6]-Gingerol is one of the pungent components in ginger which has been found to possess various pharmacological effects. However, there is insufficient information on the properties of [6]-gingerol based on controlled pharmacokinetic studies. The aim of this study was to clarify distribution profiles of [6]-gingerol in blood and biological tissues of experimental rats. Rats were administered a 240 mg/kg dose of Gs (a ginger extract, containing 53% [6]-gingerol) by oral ingestion. Plasma samples were collected at 2.5, 5, 7.5, 10, 15, 20, 30, 45 min, and 1, 1.5, 2, 3, 4 h after dosing (eight samples per time point), and brain, heart, lung, spleen, liver, kidney, stomach and small intestine tissues were collected at 5, 15, 30 min and 1, 2, 4 h after dosing (five animals per time point). Samples were prepared by a liquid-liquid extraction procedure and the extracts were assayed by HPLC-UV. After per oral application, [6]-gingerol was absorbed rapidly into the plasma, and the maximal concentration (4.23 microg/ml) was reached after 10 min post dosing. [6]-Gingerol plasma concentrations declined with time in a biexponential pattern. The elimination half-time at the terminal phase was 1.77 h and the apparent total body clearance was 40.8 l/h. When administered orally, [6]-gingerol was well distributed to the tissues examined, with the highest concentrations found in the gastrointestinal tract. Maximal concentrations of [6]-gingerol were reached in most tissues at 0.5 h post-dosing. The concentrations of [6]-gingerol in tissues all were higher than in plasma with corresponding tissue to plasma ratios greater than 1 after 0.25 h post-dose, showing high tissue partitioning and extensive distribution. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19051331     DOI: 10.1002/bdd.638

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  11 in total

1.  Examination of the pharmacokinetics of active ingredients of ginger in humans.

Authors:  Yanke Yu; Suzanna Zick; Xiaoqin Li; Peng Zou; Benjamin Wright; Duxin Sun
Journal:  AAPS J       Date:  2011-06-03       Impact factor: 4.009

2.  6-gingerdiols as the major metabolites of 6-gingerol in cancer cells and in mice and their cytotoxic effects on human cancer cells.

Authors:  Lishuang Lv; Huadong Chen; Dominique Soroka; Xiaoxin Chen; TinChung Leung; Shengmin Sang
Journal:  J Agric Food Chem       Date:  2012-11-06       Impact factor: 5.279

3.  [6]-Gingerol induces caspase-dependent apoptosis and prevents PMA-induced proliferation in colon cancer cells by inhibiting MAPK/AP-1 signaling.

Authors:  E K Radhakrishnan; Smitha V Bava; Sai Shyam Narayanan; Lekshmi R Nath; Arun Kumar T Thulasidasan; Eppurathu Vasudevan Soniya; Ruby John Anto
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

Review 4.  Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options.

Authors:  Lucija Kuna; Jelena Jakab; Robert Smolic; Nikola Raguz-Lucic; Aleksandar Vcev; Martina Smolic
Journal:  J Clin Med       Date:  2019-02-03       Impact factor: 4.241

Review 5.  Gingers and Their Purified Components as Cancer Chemopreventative Agents.

Authors:  John F Lechner; Gary D Stoner
Journal:  Molecules       Date:  2019-08-07       Impact factor: 4.411

6.  Development of starch/chitosan expandable films as a gastroretentive carrier for ginger extract-loaded solid dispersion.

Authors:  Kanidta Kaewkroek; Arpa Petchsomrit; Abdi Wira Septama; Ruedeekorn Wiwattanapatapee
Journal:  Saudi Pharm J       Date:  2022-01-05       Impact factor: 4.562

7.  Pharmacokinetic Analysis of Huangqi Guizhi Wuwu Decoction on Blood and Brain Tissue in Rats with Normal and Cerebral Ischemia-Reperfusion Injury by Microdialysis with HPLC-MS/MS.

Authors:  Hao-Zhen Zheng; Xiao Shen; Ying-Ying He; Xiang-Li Yan; Sheng-Xin Wang; Ai-Ming Yu; Li-Sheng Wang
Journal:  Drug Des Devel Ther       Date:  2020-07-21       Impact factor: 4.162

8.  Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review.

Authors:  Yiming Li; Van H Tran; Colin C Duke; Basil D Roufogalis
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-22       Impact factor: 2.629

9.  Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms.

Authors:  Shirish Dongare; Suresh K Gupta; Rajani Mathur; Rohit Saxena; Sandeep Mathur; Renu Agarwal; Tapas C Nag; Sushma Srivastava; Pankaj Kumar
Journal:  Mol Vis       Date:  2016-06-09       Impact factor: 2.367

10.  Ginger Extract and [6]-Gingerol Inhibit Contraction of Rat Entire Small Intestine.

Authors:  Usana Chatturong; Tanwarat Kajsongkram; Sakara Tunsophon; Rachanee Chanasong; Krongkarn Chootip
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.